MEDISTEM INC. (MEDS) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 73 transactions totaling $130.2M, demonstrating a bullish sentiment with $129.9M in net insider flow. The most recent transaction on Jan 5, 2024 involved a transaction of 10,000 shares valued at $0.
No significant insider buying has been recorded for MEDS in the recent period.
No significant insider selling has been recorded for MEDS in the recent period.
Based on recent SEC filings, insider sentiment for MEDS is bullish with an Insider Alignment Score of 100/100 and a net flow of $129.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at MEDISTEM INC. (MEDS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading MEDS stock, having executed 73 transactions in the past 90 days. The most active insider is Surendra K. Ajjarapu (Executive), who has made 8 transactions totaling $130.8M.
Get notified when executives and directors at MEDS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 5, 2024 | Patel Prashant | Executive | Award | 10,000 | $N/A | $0 | |
| Jan 5, 2024 | K. Ajjarapu Surendra | Executive | Award | 10,000 | $N/A | $0 | |
| Jan 5, 2024 | K. Ajjarapu Surendra | Executive | Award | 150,000 | $N/A | $0 | |
| Jan 5, 2024 | Patel Prashant | Executive | Award | 150,000 | $N/A | $0 | |
| Jan 16, 2023 | L. Peterson Michael | Executive | Award | 100,000 | $N/A | $0 | |
| Dec 30, 2022 | Jeffrey Newell A. | Executive | Award | 79,062 | $N/A | $0 | |
| Dec 13, 2022 | Huffman Janet | Executive | Award | 50,000 | $N/A | $0 | |
| Sep 1, 2022 | K. Ajjarapu Surendra | Executive | Award | 51,724 | $N/A | $0 | |
| Sep 1, 2022 | L. Pope Charles | Executive | Award | 54,525 | $N/A | $0 | |
| Sep 1, 2022 | G. Fell Donald | Executive | Award | 54,525 | $N/A | $0 | |
| Sep 1, 2022 | Huffman Janet | Executive | Award | 21,551 | $N/A | $0 | |
| Sep 1, 2022 | Patel Prashant | Executive | Award | 8,620 | $N/A | $0 | |
| Aug 25, 2022 | G. Fell Donald | Executive | Purchase | 1,500 | $1.08 | $1.6K | |
| May 20, 2022 | K. Ajjarapu Surendra | Executive | Purchase | 10,000 | $13000.00 | $130.0M | Large |
| May 20, 2022 | K. Ajjarapu Surendra | Executive | Purchase | 10,000 | $1.30 | $13.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 4 | $130.0M | 98.7% |
Award(A) | 25 | $1.6M | 1.2% |
Sale(S) | 28 | $156.9K | 0.1% |
Disposition(D) | 2 | $0 | 0.0% |
Gift(G) | 13 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insiders at MEDISTEM INC. are accumulating shares at an accelerated pace. With 11 insiders making 73 transactions totaling $130.0M in purchases versus $156.9K in sales, the net buying activity of $129.9M signals strong executive confidence. Surendra K. Ajjarapu (Executive) leads the buying activity with $130.8M in transactions across all time.